PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32801345-8	2020	Moreover, molecular deletion of Galectin-3-beta-catenin signalling synergistically improved the antitumour effect of sorafenib.	Sorafenib	117-126	galectin 3	Homo sapiens	32-42	
32801345-9	2020	CONCLUSIONS: The Galectin-3-beta-catenin-IGFBP3/vimentin signalling cascade was determined as a central mechanism controlling HCC metastasis, providing possible biomarkers for predicating vascular metastasis and sorafenib resistance, as well as potential therapeutic targets for the treatment of HCC patients.	Sorafenib	212-221	galectin 3	Homo sapiens	17-27